Cargando…
The safety of a therapeutic product composed of a combination of stem cell released molecules from adipose mesenchymal stem cells and fibroblasts
AIM: We sought to determine the safety profile of a therapeutic candidate composed of the released molecules from a combination of human adipose-derived mesenchymal stem cells and fibroblasts. Although stem cells, their progenitor cells and the molecules that are released from these cells have some...
Autores principales: | Maguire, Greg, Friedman, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Science Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7421258/ https://www.ncbi.nlm.nih.gov/pubmed/32802397 http://dx.doi.org/10.2144/fsoa-2020-0027 |
Ejemplares similares
-
Rescue of degenerating neurons and cells by stem cell released molecules: using a physiological renormalization strategy
por: Maguire, Greg, et al.
Publicado: (2019) -
Characteristic differences of cell sheets composed of mesenchymal stem cells with different tissue origins
por: Nakao, Mitsuyoshi, et al.
Publicado: (2019) -
Adipose‐derived mesenchymal stem cells differentiate into pancreatic cancer‐associated fibroblasts in vitro
por: Miyazaki, Yoshihiro, et al.
Publicado: (2020) -
Microencapsulation of cellular aggregates composed of differentiated insulin and glucagon-producing cells from human mesenchymal stem cells derived from adipose tissue
por: Jara, Claudia, et al.
Publicado: (2020) -
Correction to: Microencapsulation of cellular aggregates composed of differentiated insulin and glucagon-producing cells from human mesenchymal stem cells derived from adipose tissue
por: Jara, Claudia, et al.
Publicado: (2020)